Default company panoramic image
67306c82 b5c1 4ede 97dd 79d8c1fdb318

VenX Medical

VenX for “horizontal” phlebectomy, is a FDA cleared medical device for vein clearance of small and medium sized problematic leg veins.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Nashville, TN, USA
  • Currency USD
  • Founded September 2009
  • Employees 2
  • Website

Company Summary

VenX Medical is a venture backed medical device manufacturer founded by two active vascular surgeons, Dr. Edward Boyle and Dr. Andrew Jones. VenX Reach is a FDA cleared, IP protected, GMP compliant, single-use device useful for clearing superficial varicosities associated with unsightly and problematic veins. This novel device provides an adjunct, uniquely effective vein clearance modality to traditional sclerotherapy and micro-Phlebectomy.


  • Default avatar
    Jerry Gibson
    Executive Board Chairman

    19 years of executive positions in medical startups and technology turnaround events. Previously President and CEO of Critical Perfusion. Also, 15 years Executive positions with Siemens Medical Solutions. Currently serves on several Boards of Medical Technology companies, including the External Advisory Board for the University of California/National Science Foundation for Biophotonics Science and Technology.

  • Default avatar
    Julene Cray
    President, Chief Commercial Officer

    RN, BSN, MBA 25 years in clinical, sales and sales management in medical device companies featuring lasers, RF, and mircrowave technology. Previously, Director of Sales positions at Miramar Labs and Solta Medical (grew revenues from zero to $120 M) Involved in 3 new product launches with 2 startup companies, as well as pre-IPO and merger/acquisitions sales team functions.

  • Default avatar
    Andrew Jones, MD
    Chief Medical Officer

    Dr. Jones is a board certified general surgeon with a special interest in the management of venous disease. He completed medical school at the University of Minnesota Medical School, where he graduated with honors. He then went to Oregon Health and Science University for his general surgery training and additional training in Laparoscopic surgery. While at OHSU, Dr. Jones won multiple awards for his research on esophageal disease. Additionally,

  • Default avatar
    Mike Morales
    Operations Consultant

    : 20 years of customer service and business operations experience in startups and large public medical device companies including past positions as Director of CS Nellcor Puritan Bennett (acquired by Mallinckrodt $1.8 B), Senior Director VidaMed (acquired by Medtronic $300M); Senior Director of CS/Sales Administrations Solta Medical (grew revenues from zero to $120M); most recently Senior Director Customer Experience at MyoScience.

  • Default avatar
    Jon Kitahara
    Marketing Consultant

    35 years of health industry sales and marketing experience, from VC funded pre-IPO enterprises to industry leaders such as Syntex, Mallinckrodt and Johnson and Johnson. Most recently, Director of Marketing VNUS Medical (acquired by Covidien).

  • Default avatar
    Pam Buckman
    Quality/Regulatory Consultant

    RN, MSN - 33 years of Clinical and Regulatory consulting exclusively to medical device companies. Former Vice President, Clinical/Regulatory for Thermage, currently President of Buckman Company, Inc – extensive experience with global clinical programs and marketing submissions to regulators in US, Canada and Mexico. FDA experience with 510(k), IDE, PMA and HDE submissions.


  • Default avatar
    Gloria Skigen, Martin and Chioffi LLP
    Default avatar
    Meredith Albright, CPA, Jacobs Cohen and Associates

Previous Investors

  • Default avatar
    The Mountain Group (Joe Cook lll) and TriStar Ventures (BrianLaden, PhD)